Targeting ceramide metabolism in obesity
- PMID: 27382035
- DOI: 10.1152/ajpendo.00133.2016
Targeting ceramide metabolism in obesity
Abstract
Obesity is a major health concern that increases the risk for insulin resistance, type 2 diabetes (T2D), and cardiovascular disease. Thus, an enormous research effort has been invested into understanding how obesity-associated dyslipidemia and obesity-induced alterations in lipid metabolism increase the risk for these diseases. Accordingly, it has been proposed that the accumulation of lipid metabolites in organs such as the liver, skeletal muscle, and heart is critical to these obesity-induced pathologies. Ceramide is one such lipid metabolite that accumulates in tissues in response to obesity, and both pharmacological and genetic strategies that reduce tissue ceramide levels yield salutary actions on overall metabolic health. We will review herein why ceramide accumulates in tissues during obesity and how an increase in intracellular ceramide impacts cellular signaling and function as well as potential mechanisms by which reducing intracellular ceramide levels improves insulin resistance, T2D, atherosclerosis, and heart failure. Because a reduction in skeletal muscle ceramide levels is frequently associated with improvements in insulin sensitivity in humans, the beneficial findings reported for reducing ceramides in preclinical studies may have clinical application in humans. Therefore, modulating ceramide metabolism may be a novel, exciting target for preventing and/or treating obesity-related diseases.
Keywords: ceramide; insulin resistance; insulin signaling; obesity; serine palmitoyltransferase; sphingolipids.
Copyright © 2016 the American Physiological Society.
Similar articles
-
Sphingolipids as a Culprit of Mitochondrial Dysfunction in Insulin Resistance and Type 2 Diabetes.Front Endocrinol (Lausanne). 2021 Mar 18;12:635175. doi: 10.3389/fendo.2021.635175. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33815291 Free PMC article. Review.
-
Myriocin treatment affects lipid metabolism in skeletal muscles of rats with streptozotocin-induced type 1 diabetes.Adv Med Sci. 2017 Mar;62(1):65-73. doi: 10.1016/j.advms.2016.04.003. Epub 2016 May 9. Adv Med Sci. 2017. PMID: 28189121
-
Ceramides - Lipotoxic Inducers of Metabolic Disorders.Trends Endocrinol Metab. 2015 Oct;26(10):538-550. doi: 10.1016/j.tem.2015.07.006. Trends Endocrinol Metab. 2015. PMID: 26412155 Review.
-
Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells.Int J Mol Sci. 2019 Jan 23;20(3):479. doi: 10.3390/ijms20030479. Int J Mol Sci. 2019. PMID: 30678043 Free PMC article. Review.
-
Targeting sphingolipid metabolism in the treatment of obesity/type 2 diabetes.Expert Opin Ther Targets. 2015;19(8):1037-50. doi: 10.1517/14728222.2015.1028359. Epub 2015 Mar 26. Expert Opin Ther Targets. 2015. PMID: 25814122 Review.
Cited by
-
A Novel Combination of Fruits and Vegetables Prevents Diet-Induced Hepatic Steatosis and Metabolic Dysfunction in Mice.J Nutr. 2020 Nov 19;150(11):2950-2960. doi: 10.1093/jn/nxaa259. J Nutr. 2020. PMID: 32939550 Free PMC article.
-
The Developmental Implications of Muscle-Targeted Magnetic Mitohormesis: A Human Health and Longevity Perspective.Bioengineering (Basel). 2023 Aug 12;10(8):956. doi: 10.3390/bioengineering10080956. Bioengineering (Basel). 2023. PMID: 37627841 Free PMC article. Review.
-
Alpha-mangostin improves endothelial dysfunction in db/db mice through inhibition of aSMase/ceramide pathway.J Cell Mol Med. 2021 Apr;25(7):3601-3609. doi: 10.1111/jcmm.16456. Epub 2021 Mar 14. J Cell Mol Med. 2021. PMID: 33719188 Free PMC article.
-
Alterations of lipid homeostasis in morbid obese patients are partly reversed by bariatric surgery.iScience. 2024 Aug 26;27(9):110820. doi: 10.1016/j.isci.2024.110820. eCollection 2024 Sep 20. iScience. 2024. PMID: 39297163 Free PMC article.
-
Neutral sphingomyelinase-2 and cardiometabolic diseases.Obes Rev. 2021 Aug;22(8):e13248. doi: 10.1111/obr.13248. Epub 2021 Mar 18. Obes Rev. 2021. PMID: 33738905 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases